HG

Harald-Gerhard Geppert

GG Ganymed Pharmaceuticals Gmbh: 8 patents #8 of 49Top 20%
JM Johannes Gutenberg-Universität Mainz: 4 patents #12 of 93Top 15%
AP Astellas Pharma: 2 patents #350 of 954Top 40%
Overall (All Time): #496,381 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
11739139 Monoclonal antibodies against Claudin-18 for treatment of cancer Ugur Sahin, Ozlem Tureci, Dirk Usener, Stefan Fritz, Christoph Uherek +3 more 2023-08-29
10738108 Monoclonal antibodies against claudin-18 for treatment of cancer Ugur Sahin, Ozlem Tureci, Dirk Usener, Stefan Fritz, Christoph Uherek +3 more 2020-08-11
10174104 Monoclonal antibodies against claudin-18 for treatment of cancer Ugur Sahin, Ozlem Tureci, Dirk Usener, Stefan Fritz, Christoph Uherek +3 more 2019-01-08
10017564 Monoclonal antibodies against claudin-18 for treatment of cancer Ugur Sahin, Ozlem Tureci, Dirk Usener, Stefan Fritz, Christoph Uherek +3 more 2018-07-10
9775785 Antibody to genetic products differentially expressed in tumors and the use thereof Ozlem Tureci, Ugur Sahin, Michael Koslowski, Stephan Fritz 2017-10-03
9751934 Monoclonal antibodies against claudin-18 for treatment of cancer Ugur Sahin, Ozlem Tureci, Dirk Usener, Stefan Fritz, Christoph Uherek +3 more 2017-09-05
9499609 Monoclonal antibodies against claudin-18 for treatment of cancer Ugur Sahin, Ozlem Tureci, Dirk Usener, Stefan Fritz, Christoph Uherek +3 more 2016-11-22
9212228 Monoclonal antibodies against claudin-18 for treatment of cancer Ugur Sahin, Ozlem Tureci, Dirk Usener, Stefan Fritz, Christoph Uherek +3 more 2015-12-15
9044382 Genetic products differentially expressed in tumors and the use thereof Ozlem Tureci, Ugur Sahin, Michael Koslowski, Stefan Fritz 2015-06-02
8168427 Monoclonal antibodies against claudin-18 for treatment of cancer Ugur Sahin, Ozlem Tureci, Dirk Usener, Stefan Fritz, Cristoph Uherek +3 more 2012-05-01